XML 22 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Details 4) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Patents    
Accumulated amortization $ (215,969) $ (190,770)
Total net patents and patent applications 248,971 237,606
Other Accrued Liabilities    
Warranty 35,000 55,000
Sales commissions 38,065 29,492
Lease normalization 6,310 36,610
Sales and use tax 18,108 37,460
Marketing fees 10,560 10,279
Legal and audit fees 45,439 31,426
Payroll taxes 23,554 25,932
Medical device tax 8,425 63,808
Employment agreement 120,000 123,980
Trade shows 50,000  
Miscellaneous 53,088 32,184
Total other accrued liabilities 408,549 446,171
Income Taxes    
ASC 740 liability 0  
Unrecognized tax benefits 0  
Amount of income tax related interest or penalties assessed or recorded 0  
Impact on effective tax rate due to adoption of ASC 740 0.00%  
Sales Recognition    
Obligations related to product sales 0  
Medical Device Tax    
Excise tax rate on the sale of certain medical devices (as a percent) 2.30%  
Patents
   
Patents    
Economic or legal life 20 years  
Patents issued 367,217 243,721
Accumulated amortization (215,969) (190,770)
Patents issued, net of accumulated amortization 151,248 52,951
Patent applications 97,723 184,655
Total net patents and patent applications 248,971 237,606
Expected annual amortization expense related to patents and patent applications    
2015 20,934  
2016 20,242  
2017 20,011  
2018 20,011  
2019 and following 167,773  
Total $ 248,971